Bolognesi M, Sacerdoti D, Merkel C, Gerunda G, Maffei-Faccioli A, Angeli P, Jemmolo R M, Bombonato G, Gatta A
Servizio di Spleno-Epatologia, Istituto di Medicina Clinica, Policlinico Universitario, Padova, Italy.
Hepatology. 1996 May;23(5):1035-40. doi: 10.1002/hep.510230515.
The spleen plays a pivotal role in the pathogenesis and maintenance of portal hypertension. Few data exist about splenic hemodynamics evaluated by duplex sonography in this condition. Twenty-six normal subjects, 207 patients with portal hypertension of various causes, and in different splenoportal hemodynamic conditions, and 31 patients with liver transplantation were evaluated. In each patient the splenic resistive index (RI = peak systolic--end diastolic velocity/peak systolic velocity) and pulsatility index (PI = peak systolic--end diastolic velocity/mean velocity) were measured. In 17 cirrhotic patients, splenic indices were compared with portal hemodynamics as invasively evaluated by hepatic vein catheterization. In the various groups, RI and PI were respectively: normal subjects, 0.51 +/- 0.05 and 0.72 +/- 0.11; cirrhotic patients with hepatopetal portal blood flow (n = 167), 0.64 +/- 0.08 and 1.03 +/- 0.24; cirrhotic patients with hepatofugal portal flow (n = 3), 0.74 +/- 0.08 and 1.27 +/- 0.08; cirrhotic patients with portal vein thrombosis (n = 9), 0.74 +/- 0.08 and 1.36 +/- 0.34; patients with noncirrhotic obstruction of the portal system (n = 7), 0.69 +/- 0.11 and 1.16 +/- 0.28; cirrhotic patients with surgical decompression of splenic vein system (n = 21), 0.54 +/- 0.07 and 0.76 +/- 0.15; patients with liver transplantation (n = 31), 0.50 +/- 0.08 and 0.70 +/- 0.15. Both RI and PI were significantly higher in cirrhotic patients with hepatopetal portal flow compared with controls (P < .0001), and even higher in cirrhotic patients with portal vein thrombosis (P < .004 and P < .001 in comparison with RI and PI values of cirrhotic patients). In patients with noncirrhotic portal vein thrombosis, splenic impedance indices were higher than those in controls (RI and PI P < .0001). Cirrhotic patients who underwent surgery for the therapy of portal hypertension showed splenic impedance indices significantly decreased compared with other cirrhotic patients (RI and PI P < .0001). In patients who underwent liver transplantation, splenic impedance indices were the same as those in controls. In 23 of the 52 patients surgically treated (surgical shunt or liver transplantation), impedance indices were evaluated both before and after surgical treatment. All these patients showed a decrease in splenic impedance indices (RI and PI, P < .0001) after surgical treatment. RI and PI values were higher in patients with large esophageal varices as compared with patients without or with small varices (P < .02 and P < .01). RI and PI values were not related to age, mean arterial pressure, sex, Child-Turcotte-Pugh score, presence of ascites, or cause. A significant correlation was found between splenic impedance indices and portal resistance as evaluated by hepatic vein catheterization (r = .80, P < .001 for RI values; r = .87, P < .001 for PI values). In conclusion, this study shows that splenic impedance indices are increased in cirrhotic patients, and seems to demonstrate that in patients with cirrhosis these indices reflect portal vein blood flow resistance.
脾脏在门静脉高压的发病机制及维持过程中起关键作用。关于在这种情况下通过双功超声评估脾血流动力学的数据较少。对26名正常受试者、207例各种病因导致门静脉高压且处于不同脾门静脉血流动力学状态的患者以及31例肝移植患者进行了评估。在每位患者中测量脾阻力指数(RI = 收缩期峰值速度 - 舒张末期速度/收缩期峰值速度)和搏动指数(PI = 收缩期峰值速度 - 舒张末期速度/平均速度)。在17例肝硬化患者中,将脾指数与通过肝静脉插管进行有创评估的门静脉血流动力学进行了比较。在各个组中,RI和PI分别为:正常受试者,0.51±0.05和0.72±0.11;门静脉血流向肝的肝硬化患者(n = 167),0.64±0.08和1.03±0.24;门静脉血流离肝的肝硬化患者(n = 3),0.74±0.08和1.27±0.08;门静脉血栓形成的肝硬化患者(n = 9),0.74±0.08和1.36±0.34;门静脉系统非肝硬化性梗阻患者(n = 7),0.69±0.11和1.16±0.28;脾静脉系统手术减压的肝硬化患者(n = 21),0.54±0.07和0.76±0.15;肝移植患者(n = 31),0.50±0.08和0.70±0.15。门静脉血流向肝的肝硬化患者的RI和PI均显著高于对照组(P <.0001),门静脉血栓形成的肝硬化患者更高(与肝硬化患者的RI和PI值相比,P <.004和P <.001)。在非肝硬化性门静脉血栓形成患者中,脾阻抗指数高于对照组(RI和PI,P <.0001)。接受门静脉高压治疗手术的肝硬化患者的脾阻抗指数与其他肝硬化患者相比显著降低(RI和PI,P <.0001)。在接受肝移植的患者中,脾阻抗指数与对照组相同。在52例接受手术治疗(手术分流或肝移植)的患者中的23例中,在手术治疗前后评估了阻抗指数。所有这些患者在手术治疗后脾阻抗指数均降低(RI和PI,P <.0001)。与无或有小静脉曲张的患者相比,有大食管静脉曲张的患者的RI和PI值更高(P <.02和P <.01)。RI和PI值与年龄、平均动脉压、性别、Child-Turcotte-Pugh评分、腹水的存在或病因无关。通过肝静脉插管评估发现脾阻抗指数与门静脉阻力之间存在显著相关性(RI值,r =.80,P <.001;PI值,r =.87,P <.001)。总之,本研究表明肝硬化患者的脾阻抗指数升高,并且似乎表明在肝硬化患者中这些指数反映了门静脉血流阻力。